STAAR Surgical (STAA) awards CFO RSUs, options and PSUs
Rhea-AI Filing Summary
STAAR Surgical Co (STAA) reported equity compensation and vesting events for its Chief Financial Officer & EVP, Deborah J. Andrews. On August 14, 2026, she received 4,975 Restricted Stock Units, plus a stock option for 8,952 shares at an exercise price of $26.18 per share expiring on August 13, 2036. She also received a performance stock option for 29,159 shares at $26.18 per share, vesting over a performance period with stock-price hurdles of $50.00, $75.00 and $100.00 per share and additional time-vesting conditions. Separately, the third tranche of 5,233 performance stock units under the 2025 PSU Program vested, converting into common shares, of which 2,662 shares were withheld to satisfy taxes.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,571 shares
Net Buy
6 txns
Insider
ANDREWS DEBORAH J
Role
Chief Financial Officer & EVP
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F2, F3, F4 | 4,975 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) F5 | 8,952 | $0.00 | $0.00 |
| Grant/Award | Performance Stock Option (right to buy) F6 | 29,159 | $0.00 | $0.00 |
| Exercise | Performance Stock Units F7 | 5,233 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,233 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F1 | 2,662 | $26.18 | $70K |
Holdings After Transaction:
Restricted Stock Units — 4,975 shares (Direct);
Stock Option (right to buy) — 8,952 shares (Direct);
Performance Stock Option (right to buy) — 29,159 shares (Direct);
Performance Stock Units — 41,452 shares (Direct);
Common Stock — 38,910 shares (Direct)
Footnotes (7)
- F1. On May 15, 2026, the third tranche of 5,233 performance stock units ("PSUs") awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 2,662 shares were withheld to satisfy taxes.
- F2. Each restricted stock unit ("RSU") represents the right to receive one share of STAAR Surgical Company ("Company") common stock upon vesting.
- F3. The Reporting Person was granted Company RSUs on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter.
- F4. The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter.
- F5. The Reporting Person was granted an option to purchase 8,952 shares of Company common stock. The shares underlying the option vest over three years from the Grant Date, with one-third vesting on the first anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installment thereafter.
- F6. The Reporting Person was granted a performance option to purchase 29,159 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter.
- F7. Represents the settlement of the third tranche of PSUs awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
Key Figures
RSUs granted: 4,975 shares
Stock option shares: 8,952 shares
Stock option exercise price: $26.18 per share
+5 more
8 metrics
RSUs granted
4,975 shares
Restricted Stock Units granted to CFO on August 14, 2026
Stock option shares
8,952 shares
Standard stock option granted at $26.18 per share
Stock option exercise price
$26.18 per share
Exercise price for 8,952-share option expiring August 13, 2036
Performance stock option shares
29,159 shares
Performance stock option granted at $26.18 per share
PSUs vested (third tranche)
5,233 units
Third tranche under 2025 PSU Program vested on May 15, 2026
Shares withheld for taxes
2,662 shares
Withheld from PSU settlement to satisfy tax obligations
Performance stock-price hurdles
$50.00, $75.00, $100.00 per share
Price hurdles for performance stock option vesting
Performance option term
10 years
Performance period ends on change in control or 10-year anniversary
Key Terms
Restricted Stock Units, Performance Stock Units, performance option, Rule 16b-3(d), +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents the right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance Stock Units financial
"the third tranche of 5,233 performance stock units ("PSUs") awarded"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
performance option financial
"The Reporting Person was granted a performance option to purchase 29,159 shares"
Rule 16b-3(d) regulatory
"The original grant was exempt pursuant to Rule 16b-3(d) and was not"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
stock-price hurdles financial
"subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00"
FAQ
What equity awards did STAAR Surgical (STAA) grant to CFO Deborah Andrews on August 14, 2026?
Deborah Andrews received 4,975 RSUs, a stock option for 8,952 shares at $26.18, and a performance stock option for 29,159 shares at $26.18, all relating to STAAR Surgical common stock and subject to multi-year vesting conditions.
What are the vesting terms of the RSUs granted to the STAAR Surgical (STAA) CFO?
The 4,975 RSUs vest one-third on the first anniversary of the August 14, 2026 grant date, with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter, contingent on continued service.
What are the key terms of the new stock option granted by STAAR Surgical (STAA) to its CFO?
The CFO was granted an option to purchase 8,952 shares of common stock at $26.18 per share, vesting over three years (one-third after one year, remaining two-thirds in 24 monthly installments) and expiring on August 13, 2036.
How does the performance stock option for STAAR Surgical (STAA) CFO work?
The performance option covers 29,159 shares at $26.18 per share, with a performance period ending on a change in control or the 10-year anniversary, subject to stock-price hurdles of $50, $75, and $100 and staged time vesting.
What happened with the 2025 PSU Program award for STAAR Surgical (STAA) CFO?
On May 15, 2026, the third tranche of 5,233 PSUs vested under the 2025 PSU Program. These settled into common shares, with 2,662 shares withheld to satisfy taxes based on Compensation Committee certification of performance goals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
